Pursuant to section 105(5A) of the Medicines Act 1981, I, Audrey Sonerson, Director-General of Health,
hereby declare the following prescription medicines are specified prescription medicines for the purposes of
the Medicines (Designated Podiatrist Prescriber) Regulations 2025.
Every reference to a medicine in this notice applies whether the medicine is synthetic in origin or is from
biological or mineral sources.
Unless specific reference is made otherwise, every reference applies also to medicines that are:
- preparations and admixtures containing any proportion of any substance listed in the notice.
- salts and esters of any substance listed in the notice.
- preparations or extracts of biological materials listed in the notice.
- salts or oxides of elements listed in the notice.
Where any reference is modified by a statement of the strength of the medicine, the strength is calculated
using the free acid, base, alcohol, or element unless specifically stated otherwise.
- Adrenaline
- Amoxicillin
- Betamethasone
- Bupivacaine
- Celecoxib
- Cephalexin
- Clavulanic acid
- Dexamethasone
- Flucloxacillin
- Hydrocortisone
- Ibuprofen
- Methylprednisolone
- Metronidazole
- Mometasone
- Naproxen
- Paracetamol
- Prilocaine
- Probenecid
- Ropivacaine
- Sulfamethoxazole
- Triamcinolone
- Trimethoprim
Dated at Wellington this 15th day of May 2025.
SANDRA GALE, Chief Executive and Registrar, Podiatrists Board of New Zealand | Te Poari Tiaki Waewae O Aotearoa.